Cedarburg Hauser Pharmaceuticals

News and Events

Cedarburg Hauser Granted DEA Registration for Denver Manufacturing Facility

Denver, CO (February 27, 2013) – Cedarburg Hauser Pharmaceuticals (CHP), a contract development and manufacturing organization (CDMO), announced today that its Denver, Colorado facility has been granted registration as a manufacturer of schedule II-V controlled substances by the U.S Drug Enforcement Agency (DEA). The new DEA registration status is the result of a concerted effort [...]

Continue Reading →

Posted in: News

Leave a Comment: (0) →

DCAT Week ’13

  Cedarburg Hauser Pharmaceuticals will be attending DCAT Week ’13 in New York, NY.  The meeting will be held from March 11-14 and is based out of the Waldorf Astoria. Attendees are invited to schedule a meeting with Cedarburg Hauser at our suite in the near by Kimberly Hotel to learn about our API development [...]

Continue Reading →

Posted in: Calendar

Leave a Comment: (0) →

InformEx 2013

Cedarburg Hauser Pharmaceuticals will be exhibiting at InformEx USA in Anaheim, CA.  The exhibition will be held February 20-22nd with showcases held on February 19th. Attendees are invited to visit Cedarburg Hauser’s booth (#1207) to learn about our API development and manufacturing capabilities. To schedule a meeting with our team, please fill out the short [...]

Continue Reading →

Posted in: Calendar

Leave a Comment: (0) →

Cedarburg Hauser Promotes John K. Lynch to Chief Scientific Officer

Grafton, WI (November 6, 2012) – Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract development and manufacturing organization (CDMO), has announced the appointment of John K. Lynch, Ph.D. as its Chief Scientific Officer (CSO). Dr. Lynch has served as Cedarburg Hauser’s Director of Research and Development for the last three years, where he oversaw development projects [...]

Continue Reading →

Posted in: News

Leave a Comment: (0) →

Cedarburg Hauser Adds Plant Capacity

Makes Additional Capital Investments in Response to Demand for Commercial API Grafton, WI (September 25, 2012) – Cedarburg Hauser Pharmaceuticals (CHP) has expanded the capacity of its Wisconsin based active pharmaceutical ingredient (API) manufacturing plant. The expansion efforts are a result of an increased demand for contract manufacturing of commercial APIs and are accompanied by [...]

Continue Reading →

Posted in: News

Leave a Comment: (0) →

IVT Method Development and Validation Conference

Dr. Rafail Usatinsky (Manager, QC & Analytical Services) leading a Workshop at the Institute of Validation’s 9th Annual Method Development & Validation Conference. The workshop, titled Pharmaceutical Impurities Identification: Method Development Strategies to Ensure Compliant and Efficient Processes are in Place, will took place on Wednesday, September 12th. It was be divided into four sections: [...]

Continue Reading →

Posted in: Calendar

Leave a Comment: (0) →

CPhI Worldwide 2012

Cedarburg Hauser Pharmaceuticals will be attending CPhI World-Wide 2012 in Madrid, Spain. Cedarburg Hauser will be represented at the show by our CEO, Executive Vice President, and Director of Project Management. To schedule a meeting with our team, please fill out the short form below. A member of our team will get back to you [...]

Continue Reading →

Posted in: Calendar

Leave a Comment: (0) →

Future 50 Award

Cedarburg Hauser Pharmaceuticals Receives Future 50 Award Grafton, WI – Cedarburg Hauser Pharmaceuticals, a contract development & manufacturing organization (CDMO) specializing in active pharmaceutical ingredients, has received the Metropolitan Milwaukee Association of Commerce (MMAC) Future 50 Award. The future 50 award recognizes the achievements of privately-owned business in the seven county Milwaukee region that have [...]

Continue Reading →

Posted in: News

Leave a Comment: (0) →

Top 10 Standout CMO

Cedarburg Hauser Named Top 10 CMO by FiercePharma Manufacturing In an article posted on October 6th, FiercePharma Manufacturing, a leading pharmaceutical electronic trade publication, named Cedarburg Hauser Pharmaceuticals one of the “Top 10 Standout CMOs”. FiercePharma Manufacturing worked with respected pharmaceutical industry research company, Nice Insight, to come up with the Top 10 list based [...]

Continue Reading →

Posted in: News

Leave a Comment: (0) →
Page 1 of 2 12